Literature DB >> 16633348

Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer.

Brian D Brown1, Mary Anna Venneri, Anna Zingale, Lucia Sergi Sergi, Luigi Naldini.   

Abstract

MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression by repressing translation of target cellular transcripts. Increasing evidence indicates that miRNAs have distinct expression profiles and play crucial roles in numerous cellular processes, although the extent of miRNA regulation is not well known. By challenging mice with lentiviral vectors encoding target sequences of endogenous miRNAs, we show the efficiency of miRNAs in sharply segregating gene expression among different tissues. Transgene expression from vectors incorporating target sequences for mir-142-3p was effectively suppressed in intravascular and extravascular hematopoietic lineages, whereas expression was maintained in nonhematopoietic cells. This expression profile, which could not be attained until now, enabled stable gene transfer in immunocompetent mice, thus overcoming a major hurdle to successful gene therapy. Our results provide novel in situ evidence of miRNA regulation and demonstrate a new paradigm in vector design with applications for genetic engineering and therapeutic gene transfer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16633348     DOI: 10.1038/nm1398

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  196 in total

Review 1.  Studying the mononuclear phagocyte system in the molecular age.

Authors:  Andrew Chow; Brian D Brown; Miriam Merad
Journal:  Nat Rev Immunol       Date:  2011-10-25       Impact factor: 53.106

2.  Gene therapy: too much splice can spoil the dish.

Authors:  Didier Trono
Journal:  J Clin Invest       Date:  2012-04-23       Impact factor: 14.808

3.  Tracking differentiating neural progenitors in pluripotent cultures using microRNA-regulated lentiviral vectors.

Authors:  Rohit Sachdeva; Marie E Jönsson; Jenny Nelander; Agnete Kirkeby; Carolina Guibentif; Bernhard Gentner; Luigi Naldini; Anders Björklund; Malin Parmar; Johan Jakobsson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

4.  In vitro and in vivo characterization of microRNA-targeted alphavirus replicon and helper RNAs.

Authors:  Kurt I Kamrud; V McNeil Coffield; Gary Owens; Christin Goodman; Kim Alterson; Max Custer; Michael A Murphy; Whitney Lewis; Sarah Timberlake; Elizabeth K Wansley; Peter Berglund; Jonathan Smith
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

5.  A microRNA-regulated and GP64-pseudotyped lentiviral vector mediates stable expression of FVIII in a murine model of Hemophilia A.

Authors:  Hideto Matsui; Carol Hegadorn; Margareth Ozelo; Erin Burnett; Angie Tuttle; Andrea Labelle; Paul B McCray; Luigi Naldini; Brian Brown; Christine Hough; David Lillicrap
Journal:  Mol Ther       Date:  2011-02-01       Impact factor: 11.454

6.  CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors.

Authors:  Rasmus O Bak; Matthew H Porteus
Journal:  Cell Rep       Date:  2017-07-18       Impact factor: 9.423

Review 7.  Retroviral vector interactions with hematopoietic cells.

Authors:  Elizabeth M Everson; Grant D Trobridge
Journal:  Curr Opin Virol       Date:  2016-08-10       Impact factor: 7.090

Review 8.  CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors.

Authors:  Dan Wang; Feng Zhang; Guangping Gao
Journal:  Cell       Date:  2020-04-02       Impact factor: 41.582

Review 9.  Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.

Authors:  Timothy C Nichols; Aaron M Dillow; Helen W G Franck; Elizabeth P Merricks; Robin A Raymer; Dwight A Bellinger; Valder R Arruda; Katherine A High
Journal:  ILAR J       Date:  2009

10.  Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting.

Authors:  Elizabeth J Kelly; Rebecca Nace; Glen N Barber; Stephen J Russell
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.